197 related articles for article (PubMed ID: 20453719)
1. Should expedited partner treatment for women with Trichomonas vaginalis be recommended?
Kissinger P
Sex Transm Dis; 2010 Jun; 37(6):397-8. PubMed ID: 20453719
[No Abstract] [Full Text] [Related]
2. Chemotherapeutic options for the treatment of human trichomoniasis.
Küng E; Fürnkranz U; Walochnik J
Int J Antimicrob Agents; 2019 Feb; 53(2):116-127. PubMed ID: 30612993
[TBL] [Abstract][Full Text] [Related]
3. Management of trichomonas vaginalis in women with suspected metronidazole hypersensitivity.
Helms DJ; Mosure DJ; Secor WE; Workowski KA
Am J Obstet Gynecol; 2008 Apr; 198(4):370.e1-7. PubMed ID: 18221927
[TBL] [Abstract][Full Text] [Related]
4. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.
Muzny CA; Blackburn RJ; Sinsky RJ; Austin EL; Schwebke JR
Clin Infect Dis; 2014 Sep; 59(6):834-41. PubMed ID: 24928292
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of partner notification methods for prevention of trichomoniasis in women.
Schwebke JR; Desmond RA
Sex Transm Dis; 2010 Jun; 37(6):392-6. PubMed ID: 20453720
[TBL] [Abstract][Full Text] [Related]
6. Resistant trichomoniasis: successful treatment with combination therapy.
Nyirjesy P; Gilbert J; Mulcahy LJ
Sex Transm Dis; 2011 Oct; 38(10):962-3. PubMed ID: 21934573
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of medicines active against trichomoniasis vaginalis in a double-blind study].
Heiss H
Wien Med Wochenschr; 1971 Nov; 121(46):832-4. PubMed ID: 4945029
[No Abstract] [Full Text] [Related]
8. Prolonged vaginal and oral metronidazole for refractory Trichomonas vaginalis: a case report.
Wood S; Kennedy CM; Galask RP
J Reprod Med; 2007 Nov; 52(11):1057-8. PubMed ID: 18161407
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study for the evaluation of the efficacy and safety of metronidazole and secnidazole in the treatment of vaginal trichomoniasis].
Buitrón García Figueroa R; Gonzalo Butrón López F; Oropez Rechy G; Romero-Cabello R
Ginecol Obstet Mex; 1997 Nov; 65():487-91. PubMed ID: 9441152
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of urogenital trichomoniasis of both sexes with tinidazol (Fasygin)].
Rainer A
Wien Med Wochenschr; 1974 Oct; 124(42-43):625-6. PubMed ID: 4548265
[No Abstract] [Full Text] [Related]
11. Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trial.
Kissinger P; Schmidt N; Mohammed H; Leichliter JS; Gift TL; Meadors B; Sanders C; Farley TA
Sex Transm Dis; 2006 Jul; 33(7):445-50. PubMed ID: 16531939
[TBL] [Abstract][Full Text] [Related]
12. Arsenical pessaries in the treatment of metronidazole-resistant Trichomonas vaginalis.
Walker PP; Hall RE; Wilson JD
Int J STD AIDS; 1997 Jul; 8(7):473. PubMed ID: 9228600
[No Abstract] [Full Text] [Related]
13. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.
Meites E; Gaydos CA; Hobbs MM; Kissinger P; Nyirjesy P; Schwebke JR; Secor WE; Sobel JD; Workowski KA
Clin Infect Dis; 2015 Dec; 61 Suppl 8(Suppl 8):S837-48. PubMed ID: 26602621
[TBL] [Abstract][Full Text] [Related]
14. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis.
Wendel KA; Erbelding EJ; Gaydos CA; Rompalo AM
Clin Infect Dis; 2002 Sep; 35(5):576-80. PubMed ID: 12173132
[TBL] [Abstract][Full Text] [Related]
15. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.
Cudmore SL; Delgaty KL; Hayward-McClelland SF; Petrin DP; Garber GE
Clin Microbiol Rev; 2004 Oct; 17(4):783-93, table of contents. PubMed ID: 15489348
[TBL] [Abstract][Full Text] [Related]
16. Patient-delivered partner treatment and Trichomonas vaginalis repeat infection among human immunodeficiency virus-infected women.
Gatski M; Mena L; Levison J; Clark RA; Henderson H; Schmidt N; Rosenthal SL; Martin DH; Kissinger P
Sex Transm Dis; 2010 Aug; 37(8):502-5. PubMed ID: 20502393
[TBL] [Abstract][Full Text] [Related]
17. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
Seña AC; Bachmann LH; Hobbs MM
Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
[TBL] [Abstract][Full Text] [Related]
18. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.
Seña AC; Miller WC; Hobbs MM; Schwebke JR; Leone PA; Swygard H; Atashili J; Cohen MS
Clin Infect Dis; 2007 Jan; 44(1):13-22. PubMed ID: 17143809
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.
Kissinger PJ; Gaydos CA; Seña AC; Scott McClelland R; Soper D; Secor WE; Legendre D; Workowski KA; Muzny CA
Clin Infect Dis; 2022 Apr; 74(Suppl_2):S152-S161. PubMed ID: 35416973
[TBL] [Abstract][Full Text] [Related]
20. [Sensitivity of Trichomonas to flagyl and its importance in the treatment of Trichomonas infection in women].
Starostina ZD
Vestn Dermatol Venerol; 1973 Oct; 47(10):84-5. PubMed ID: 4544528
[No Abstract] [Full Text] [Related]
[Next] [New Search]
